Examkin

Question

Difficulty: MediumReproductive Endocrinology and Infertility

A 27-year-old woman presents to the gynecology clinic due to the absence of menses for nine months accompanied by spontaneous milky bilateral nipple discharge. She and her husband are hoping to have a child and have been having regular, unprotected intercourse for a year. A point-of-care urine pregnancy test is negative.

Arrange the following steps in the most appropriate chronological order for the evaluation and management of this patient to facilitate a safe pregnancy.

  1. 1Obtain serum prolactin and thyroid-stimulating hormone levels
  2. 2Perform magnetic resonance imaging of the pituitary gland
  3. 3Initiate medical therapy with a dopamine agonist
  4. 4Discontinue the dopamine agonist upon a positive pregnancy test
  5. 5Monitor clinically for new-onset headaches or visual changes

Answer

The correct sequence is: biochemical evaluation (Prolactin/TSH), followed by anatomical evaluation (MRI), initiation of medical therapy (dopamine agonist), discontinuation of therapy upon conception, and finally clinical monitoring during pregnancy.
The correct sequence follows the standard guidelines for managing a prolactinoma in a patient seeking fertility: biochemical confirmation, anatomical diagnosis, medical management to restore ovulation, cessation of unnecessary medication upon conception, and clinical surveillance during gestation.

Step-by-Step Solution

1
Identify the primary presentation and rule out pregnancy
The patient has secondary amenorrhea and galactorrhea, with a negative beta-hCG test.
Pregnancy is the most common cause of secondary amenorrhea and must be excluded first.
2
Determine the initial diagnostic steps
Serum prolactin and TSH are measured to confirm hyperprolactinemia and exclude primary hypothyroidism.
Hypothyroidism can cause elevated TRH, which stimulates prolactin release.
3
Determine the next diagnostic step after biochemical confirmation
An MRI of the pituitary gland is performed.
Imaging is required to identify a pituitary adenoma and determine its size (microadenoma vs. macroadenoma).
4
Select the appropriate initial treatment
Therapy with a dopamine agonist (e.g., cabergoline) is initiated.
This medical therapy inhibits prolactin secretion, restores pulsatile GnRH release, and allows for ovulation.
5
Establish the management plan upon successful conception
The dopamine agonist is discontinued.
Stopping the medication prevents unnecessary fetal exposure, as microadenomas have a low risk of significant growth during pregnancy.
6
Establish the prenatal care plan regarding the adenoma
Clinical monitoring for headaches and visual field changes is instituted.
The pituitary naturally hypertrophies during pregnancy; if symptoms of tumor expansion occur, visual field testing and MRI may be indicated.

Key Concept

Evaluation and management sequence for hyperprolactinemia-induced infertility
Estimated Time:1m 15s
Rate this question

Topics

Reproductive Endocrinology and Infertility

More questions from this topic